Table 1.
Supplements | Model | Sample Size | Administration (Dose/Day and Duration) of Supplementation | General Effects and Possible Mechanism of Action | Effects on Microbiome Composition | Refs. |
---|---|---|---|---|---|---|
Probiotic | ||||||
Lactobacillus casei Shirota | SAMP8 mice | 24 | 1 × 108 or 1 × 109 CFU/mouse/day × 12 weeks | ↓ signaling mediators (inflammatory cytokines and SCFAs); = mitochondrial and muscle functions |
↑ Odoribacter, ↑ Oscillibacter, ↑ Lachnospiraceae UCG 006 |
[148] |
Bifidobacterium longum OLP-01 | ICR mice | 40 | 2.05 × 109; 4.10 × 109; and 1.03 × 1010 CFU/kg/day for 4 weeks | ↓ lactate, ammonia, and CK levels | ↑ Lactobacillus, ↑ Clostridium, ↑ Bifidobacterium, ↑ Lactococcus, ↓ Bacillus, ↓ Enterococcus, ↓ Akkermansia |
[149] |
Lacticaseibacillus paracasei PS23 | SAMP8 mice | 80 | 1 × 109 CFU/mouse/day for 12 weeks | ↑ lean mass, restored muscle strength, ↑ SOD, ↑ gpx in muscles |
[150] | |
Lactobacillus plantarum TWK10 | ICR mice | 33 | 1 × 109 CFU/mouse/day for 6 weeks | Prevention of muscle weakness associated with aging, ↑ concentration of glycogen in muscle tissue |
↓ Enterobacteriaceae, ↓ Enterococcaceae, ↑ Lactobacillaceae |
[151,152] |
Lactobacillus plantarum TWK10 | ICR mice | 24 | 2.05 × 108, 1.03 × 109 units/kg/day for 6 weeks | ↑ muscle mass (gastrocnemius muscle), ↑ energy harvesting, health promotion, performance improvement, anti-fatigue effects |
[153] | |
Limosilactobacillus fermentum DR9 | Sprague Dawley rats, | 18 | 10 log CFU/rat/day for 12 weeks | ↓ p53, increase in IGF-1 anabolic factors, prevention of aging-induced metabolic diseases |
Inhibited growth of pathogens Escherichia coli, Staphylococcus aureus, and Staphylococcus epidermidis | [154] |
Lactobacillus Paracasei OFS 0291 | ||||||
Lactobacillus helveticus OFS 1515 | ||||||
Kefir | ICR mice | 32 | 2.15, 4.31, and 10.76 g/kg/day for 4 weeks | ↑ exercise performance, ↑ forelimb grip strength, ↑ swimming time to exhaustion |
↓ Firmicutes/ Bacteroidetes ratio |
[155] |
Prebiotics | ||||||
FOS and inulin | Human | 50 | one spoon/ day for 13 weeks | ↑ levels of fatigue, ↑ muscle strength |
[156,157] | |
GOS | Human | 39 | 4 g/ twice daily for 3 weeks | Production of butyrate | ↑ bifidobacteria, ↑ lactobacilli |
[158,159] |
1-kestose | Human super-elderly patients | 6 | 10 g/day for 12 weeks | ↑ index of skeletal muscle mass, ↓ body fat |
↑ Bifidobacterium longum | [158,159] |
SCFAs | ||||||
β-hydroxy-β-methylbutyrate (HMB) | Human | 43 | 1.5 g twice daily for 12 weeks | ↑ muscle mass, ↑ muscle strength |
[160] | |
HMB/Arg/Lys mixture | Human | 77 | 2 g/5 g/1.5 g per day) for 1 year | ↑ lean tissue mass, ↑ protein turnover |
[161] | |
HMB | Human | 79 | 2 g/day for 2 or 4 weeks | ↓ urinary urea nitrogen excretion | [162,163,164,165,166,167,168] | |
HMB | Human | 31 | ↑ body fat loss | [162,163,164,165,166,167,168] | ||
HMB/Arg/Lys mixture | Human | 57 | 2/5/1.5 g per day for 12 weeks | ↑ limb circumference, ↑ leg and handgrip strength, ↑ body protein synthesis |
[162,163,164,165,166,167,168] | |
HMB/Arg/Lys mixture | Human | 77 | 2/5/1.5 g per day for 1 year | ↑ muscle mass, ↑ muscle strength |
[162,163,164,165,166,167,168] | |
HMB/Arg/Gln mixture | Human | 35 | 4 g HMB/14 g Arg/14 g Gln for 2 weeks | ↑ collagen synthesis in muscle | [162,163,164,165,166,167,168] | |
HMB | Human | 80 | (1.5 g/day) + mild fitness program for 8 weeks | ↑ muscle strength, ↑ physical performance parameters |
[162,163,164,165,166,167,168] | |
Curcumin | ||||||
BALB/c mice | 0.2% (w/w) nanoparticle curcumin mixed with normal rodent diet for 7 days | Suppression of the activation of NF-kB | ↑ butyrate-producing bacteria and Clostridium cluster IV | [169] | ||
Human | 32 | 6 tablets daily; 6000 mg for 4/8 weeks | ↑ Clostridium, ↑ Bacteroides, ↑ Citrobacter, ↑ Cronobacter, ↑ Enterobacter, ↑ Enterococcus, ↑ Klebsiella, ↑ Parabacteroides, ↑ Pseudomonas, ↓ Blautia, ↓ Ruminococcus |
[170] | ||
Curcumin + HPβCD | C57BL6J and C57BL10ScSn mice | 143 | every sixth day, for 6 months, with120 μg/kg | ↑ satellite cell commitment and recruitment | [171] | |
Quercetin | ||||||
Quercetin glycosides | Male C57BL/6J mice | Two dosages (1.5 or 3.0 g/L) for 24 weeks | ↑ Strength and rotarod performance, ↑ wet weights |
[172] | ||
Resveratrol | Wistar rats | 400 mg/kg/day | ↓ muscle fiber atrophy | [173] | ||
Ω-3 fatty acids | ||||||
Linolenic acid | Caenorhabditis elegans | 50 μg mL−1 | repair of mitochondrial function by promoting mitophagy and fighting oxidative stress | [174] |
CFU = colony-forming units; CK = creatine kinase; SOD = superoxide dismutase; IGF-1 = insulin-like growth factor-1; ↑ = increase; ↓ = decrease.